PREFERRED LOGISTICS PARTNER
As the trusted leader in personalized medicine logistics and transportation, QuickSTAT provides customized solutions and protocols to ensure the safety and integrity of your cell and gene therapies (CGT). Our CGT Center of Excellence delivers logistics expertise, temperature monitoring, chain of custody, chain of indentity and quality control processes. Our specially trained global team, with unmatched experience in the industry, will help you plan, design and support your logistics operation, so you can focus on your core business - creating cutting-edge healthcare treatments.
GENE & CELL THERAPIES
Innovative solutions for CGT therapies that ensure regulatory compliance, product integrity and patient safety.
Expertise in transporting autologous vaccines, CAR T-cell and TCR therapies as well as patient samples and aphaeresis to the CMO or clinical facilities.
Quick is the most experienced global transportation provider of cord blood, stem cells and umbilical cords for transplant and research.
Supporting Biotech companies with cell and gene therapy logistics for over 15 years.
QuickSTAT has been at the forefront of innovation, supporting the industry since its inception with unique understanding of the personalized medicine supply chain needs.
From clinical research through to commercialization, QuickSTAT has been providing biotech companies with logistics expertise, supply chain planning, and turnkey logistics solutions. Our specialists have worked with both start-up and long-established organizations to ensure seamless operational integration, successful clinical trial set up and commercial launch, utilizing GDP principles and best practices.
Cell & Gene Therapy Logistics Solutions
- Expert Temperature-Controlled Logistics
- Next Flight Out
- Provision of Qualified Packaging
- OBC - On-Board Courier
- Robust Chain of Custody
- Air Charter Services
- GPS Tracking & Leading Technology
- Dangerous Goods Transportation
- Regulatory Expertise and GDP Protocols
Quick Becomes the
Partner for the First
FDA Approved Cancer